ASCO report highlights progress against cancer in last year

ASCO report highlights progress against cancer in last year

(HealthDay)—Progress against cancer is described in the ninth annual report of the American Society of Clinical Oncology, published online Dec. 10 in the Journal of Clinical Oncology.

In a report featuring 76 studies, Jyoti D. Patel, M.D., from Northwestern University in Chicago, and colleagues reviewed research published or presented over the last year (October 2012 to September 2013) to describe clinical cancer advances. The authors note that about 1.6 million new cancer cases will be diagnosed this year in the United States, and that although overall cancer-related death rates continue to decline, cancer remains the second most common cause of death.

According to the authors, cancer genomics is increasingly being used to make treatment decisions and personalize therapy approaches. Modern genomic technology, including findings from The Cancer Genome Atlas research network, is also accelerating development of new targeted therapies. Noting the benefits of screening, two reports described new cancer screening models, which can reduce screening disparities and improve outcomes. Several studies discussed immunotherapy approaches, including drugs that block the programmed 1/programmed cell death 1 ligand 1 pathway and an approach involving reinfusion of genetically engineered autologous T cells. Nine new anticancer drugs were approved in the last year, and indications were expanded for six existing anticancer agents. New U.S. Food and Drug Administration breakthrough therapy designation is expected to accelerate development of new treatments.

"Preserving our nation's investment in is absolutely necessary to maintain and increase the momentum that brings new and improved treatments to the growing numbers of people with cancer," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Discovery paves way for personalized cancer treatment

Nov 18, 2013

A prostate cancer researcher at the University of Alberta and his team have discovered how to improve currently available cancer drugs so the medication could be personalized for individual patients.

Cancer cases up 11%, breast cancer by a fifth: WHO

Dec 12, 2013

The number of new cancer cases around the globe jumped by 11 percent in a five-year period, reaching 14.1 million in 2012, with breast cancer increasing by one-fifth, the UN health agency said Thursday.

The importance of standardizing drug screening studies

Dec 02, 2013

A bioinformatics expert at the IRCM, Benjamin Haibe-Kains, recently published an article stressing the importance of standardizing drug screening studies in the prestigious scientific journal Nature. The study supports the ne ...

Recommended for you

Early hormone therapy may be safe for women's hearts

2 hours ago

(HealthDay)—Healthy women at low risk of cardiovascular disease may be able to take hormone replacement therapy soon after menopause for a short time without harming their hearts, according to a new study.

Low yield for repeat colonoscopy in some patients

3 hours ago

(HealthDay)—Repeat colonoscopies within 10 years are of little benefit to patients who had no polyps found on adequate examination; however, repeat colonoscopies do benefit patients when the baseline examination was compromised, ...

Cell's recycling center implicated in division decisions

6 hours ago

Most cells do not divide unless there is enough oxygen present to support their offspring, but certain cancer cells and other cell types circumvent this rule. Researchers at The Johns Hopkins University have now identified ...

User comments